Last 12 months
Inside the activity.
2 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2025 Filed May 28, 2025 00:48 UTC |
Smith Jeffrey CDirector
|
GrantDeferred Share Units · Derivative | 7,659 | $23.50 | $179,986.50 |
DisclosureSEC source: 0001193805-25-000724 · e664556_4-kvue.xml · derivative · entry 2 Smith Jeffrey C · CIK 0001362697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,656 Underlying: Common Stock · 7,659 shares Expires not disclosed F2 · derivative.exercise_price: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of common stock on the settlement date). F2 · derivative.exercise_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of common stock on the settlement date). F2 · derivative.expiration_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of common stock on the settlement date). Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:35 UTC |
Perry KirkDirector
|
GrantDeferred Share Units · Derivative | 7,659 | $23.50 | $179,986.50 |
DisclosureSEC source: 0001944048-25-000156 · wk-form4_1748392530.xml · derivative · entry 1 Perry Kirk · CIK 0001685154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,614.954 Underlying: Common Stock · 7,659 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F2 · balance_after: Includes DSUs acquired as dividend equivalents. Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:35 UTC |
Godbole SeemantiniDirector
|
GrantDeferred Share Units · Derivative | 7,659 | $23.50 | $179,986.50 |
DisclosureSEC source: 0001944048-25-000155 · wk-form4_1748392520.xml · derivative · entry 1 Godbole Seemantini · CIK 0001759418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,311.662 Underlying: Common Stock · 7,659 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F2 · balance_after: Includes DSUs acquired as dividend equivalents. Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:35 UTC |
Healey MelanieDirector
|
GrantDeferred Share Units · Derivative | 7,659 | $23.50 | $179,986.50 |
DisclosureSEC source: 0001944048-25-000153 · wk-form4_1748392498.xml · derivative · entry 1 Healey Melanie · CIK 0001536208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,311.665 Underlying: Common Stock · 7,659 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F2 · balance_after: Includes DSUs acquired as dividend equivalents. Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:34 UTC |
PAWLUS KATHLEEN MDirector
|
GrantDeferred Share Units · Derivative | 7,659 | $23.50 | $179,986.50 |
DisclosureSEC source: 0001944048-25-000151 · wk-form4_1748392476.xml · derivative · entry 1 PAWLUS KATHLEEN M · CIK 0001627839 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,194.773 Underlying: Common Stock · 7,659 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F2 · balance_after: Includes DSUs acquired as dividend equivalents. Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:34 UTC |
Sneed Michael EDirector
|
GrantDeferred Share Units · Derivative | 7,659 | $23.50 | $179,986.50 |
DisclosureSEC source: 0001944048-25-000150 · wk-form4_1748392464.xml · derivative · entry 1 Sneed Michael E · CIK 0001745939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,311.664 Underlying: Common Stock · 7,659 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F2 · balance_after: Includes DSUs acquired as dividend equivalents. Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:34 UTC |
ALLISON RICHARD E JRDirector
|
GrantDeferred Share Units · Derivative | 7,659 | $23.50 | $179,986.50 |
DisclosureSEC source: 0001944048-25-000149 · wk-form4_1748392449.xml · derivative · entry 1 ALLISON RICHARD E JR · CIK 0001622500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,249.536 Underlying: Common Stock · 7,659 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F2 · balance_after: Includes DSUs acquired as dividend equivalents. Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:33 UTC |
Hofstetter SarahDirector
|
GrantDeferred Share Units · Derivative | 7,659 | $23.50 | $179,986.50 |
DisclosureSEC source: 0001944048-25-000147 · wk-form4_1748392423.xml · derivative · entry 1 Hofstetter Sarah · CIK 0001754758 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,656 Underlying: Common Stock · 7,659 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:34 UTC |
PRABHU VASANT MDirector
|
GrantDeferred Share Units · Derivative | 7,659 | $23.50 | $179,986.50 |
DisclosureSEC source: 0001944048-25-000148 · wk-form4_1748392438.xml · derivative · entry 1 PRABHU VASANT M · CIK 0001209832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,311.664 Underlying: Common Stock · 7,659 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F2 · balance_after: Includes DSUs acquired as dividend equivalents. Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:33 UTC |
Mann Erica LDirector
|
GrantDeferred Share Units · Derivative | 7,659 | $23.50 | $179,986.50 |
DisclosureSEC source: 0001944048-25-000146 · wk-form4_1748392413.xml · derivative · entry 1 Mann Erica L · CIK 0001768777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,349 Underlying: Common Stock · 7,659 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). Read SEC document |
| May 16, 2025 Filed May 17, 2025 01:32 UTC |
Smith Jeffrey CDirector
|
OtherCommon Stock, $0.01 par value | 1,124,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-25-000686 · e664529_4-kvue.xml · nonDerivative · entry 1 Smith Jeffrey C · CIK 0001362697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Starboard Value LP Disclosed balance after: 20,929,938 F2 · kind: Represents a pro rata in-kind distribution by a Starboard Account to an underlying investor for no consideration. F1 · ownership.nature: Starboard Value LP ("Starboard") serves as the investment manager or manager of certain managed accounts and private investment funds (collectively, the "Starboard Accounts"), which hold the securities reported herein and as such may be deemed to beneficially own such securities. The Reporting Person, as a Managing Member of Starboard, may be deemed to beneficially own the securities directly held by the Starboard Accounts for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. The Reporting Person expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 00:05 UTC |
Perry KirkDirector
|
GrantDeferred Share Units · Derivative | 1,076 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001944048-25-000104 · wk-form4_1743552335.xml · derivative · entry 1 Perry Kirk · CIK 0001685154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,955.954 Underlying: Common Stock · 1,076 shares Expires not disclosed F1 · security: Each Deferred Share Unit ("DSU") represents the right to receive one share of Issuer common stock. F2 · derivative.exercise_price: The DSUs represent deferral of cash compensation under the Issuer's Amended and Restated Deferred Fee Plan for Directors and will be settled in shares of common stock following the reporting person's separation from service. F1 · price: Each Deferred Share Unit ("DSU") represents the right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The DSUs represent deferral of cash compensation under the Issuer's Amended and Restated Deferred Fee Plan for Directors and will be settled in shares of common stock following the reporting person's separation from service. F2 · derivative.expiration_date: The DSUs represent deferral of cash compensation under the Issuer's Amended and Restated Deferred Fee Plan for Directors and will be settled in shares of common stock following the reporting person's separation from service. F3 · derivative.underlying_shares: Includes DSUs acquired as dividend equivalents. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 00:05 UTC |
Hofstetter SarahDirector
|
GrantDeferred Share Units · Derivative | 307 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001944048-25-000103 · wk-form4_1743552325.xml · derivative · entry 1 Hofstetter Sarah · CIK 0001754758 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,997 Underlying: Common Stock · 307 shares Expires not disclosed F1 · security: Each Deferred Share Unit ("DSU") represents the right to receive one share of Issuer common stock. F2 · derivative.exercise_price: The DSUs represent deferral of cash compensation under the Issuer's Amended and Restated Deferred Fee Plan for Directors and will be settled in shares of common stock following the reporting person's separation from service. F1 · price: Each Deferred Share Unit ("DSU") represents the right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The DSUs represent deferral of cash compensation under the Issuer's Amended and Restated Deferred Fee Plan for Directors and will be settled in shares of common stock following the reporting person's separation from service. F2 · derivative.expiration_date: The DSUs represent deferral of cash compensation under the Issuer's Amended and Restated Deferred Fee Plan for Directors and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 00:05 UTC |
ALLISON RICHARD E JRDirector
|
GrantDeferred Share Units · Derivative | 1,076 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001944048-25-000102 · wk-form4_1743552314.xml · derivative · entry 1 ALLISON RICHARD E JR · CIK 0001622500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,590.536 Underlying: Common Stock · 1,076 shares Expires not disclosed F1 · security: Each Deferred Share Unit ("DSU") represents the right to receive one share of Issuer common stock. F2 · derivative.exercise_price: The DSUs represent deferral of cash compensation under the Issuer's Amended and Restated Deferred Fee Plan for Directors and will be settled in shares of common stock following the reporting person's separation from service. F1 · price: Each Deferred Share Unit ("DSU") represents the right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The DSUs represent deferral of cash compensation under the Issuer's Amended and Restated Deferred Fee Plan for Directors and will be settled in shares of common stock following the reporting person's separation from service. F2 · derivative.expiration_date: The DSUs represent deferral of cash compensation under the Issuer's Amended and Restated Deferred Fee Plan for Directors and will be settled in shares of common stock following the reporting person's separation from service. F3 · balance_after: Includes DSUs acquired as dividend equivalents. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 20:36 UTC |
Smith Jeffrey CDirector
|
GrantDeferred Share Units · Derivative | 307 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-25-000941 · form406297362_04022025.xml · derivative · entry 2 Smith Jeffrey C · CIK 0001362697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,997 Underlying: Common Stock · 307 shares Expires not disclosed F2 · security: Each Deferred Share Unit ("DSU") represents the right to receive one share of Issuer common stock. F3 · derivative.exercise_price: The DSUs represent deferral of cash compensation under the Issuer's Amended and Restated Deferred Fee Plan for Directors and will be settled in shares of common stock following the Reporting Person's separation from service. F2 · price: Each Deferred Share Unit ("DSU") represents the right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The DSUs represent deferral of cash compensation under the Issuer's Amended and Restated Deferred Fee Plan for Directors and will be settled in shares of common stock following the Reporting Person's separation from service. F3 · derivative.expiration_date: The DSUs represent deferral of cash compensation under the Issuer's Amended and Restated Deferred Fee Plan for Directors and will be settled in shares of common stock following the Reporting Person's separation from service. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 20:23 UTC |
Lawson CarltonGroup President EMEA & LA
|
SaleCommon Stock | 17,100 | $23.03 | $393,813.00 |
DisclosureSEC source: 0001944048-25-000096 · wk-form4_1741983832.xml · nonDerivative · entry 1 Lawson Carlton · CIK 0001967003 · Group President EMEA & LA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,316.03 F1 · shares: Shares sold to cover the reporting person's tax obligation associated with vesting of Restricted Share Units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.03 to $23.04, inclusive. The reporting person undertakes to provide to Kenvue Inc., any security holder of Kenvue Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 18:54 UTC |
Dyer RussellChief Corp. Affairs Officer
|
GrantStock Options · Derivative | 52,325 | $0.00 Strike: $23.92 | $0.00 |
DisclosureSEC source: 0001944048-25-000089 · wk-form4_1741820039.xml · derivative · entry 2 Dyer Russell · CIK 0002023971 · Chief Corp. Affairs Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,325 Underlying: Common Stock · 52,325 shares Expires 2035-03-10 F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 18:54 UTC |
Dyer RussellChief Corp. Affairs Officer
|
GrantRestricted Stock Units · Derivative | 6,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000089 · wk-form4_1741820039.xml · derivative · entry 1 Dyer Russell · CIK 0002023971 · Chief Corp. Affairs Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,270 Underlying: Common Stock · 6,270 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 18:53 UTC |
England CharmaineChief Growth Officer
|
GrantStock Options · Derivative | 59,302 | $0.00 Strike: $23.92 | $0.00 |
DisclosureSEC source: 0001944048-25-000086 · wk-form4_1741820010.xml · derivative · entry 2 England Charmaine · CIK 0002003894 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,302 Underlying: Common Stock · 59,302 shares Expires 2035-03-10 F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 18:53 UTC |
England CharmaineChief Growth Officer
|
GrantRestricted Stock Units · Derivative | 7,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000086 · wk-form4_1741820010.xml · derivative · entry 1 England Charmaine · CIK 0002003894 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,107 Underlying: Common Stock · 7,107 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 18:53 UTC |
Tavares BernardoChief Tech & Data Officer
|
GrantStock Options · Derivative | 40,290 | $0.00 Strike: $23.92 | $0.00 |
DisclosureSEC source: 0001944048-25-000085 · wk-form4_1741819997.xml · derivative · entry 2 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,290 Underlying: Common Stock · 40,290 shares Expires 2035-03-10 F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 18:53 UTC |
Tavares BernardoChief Tech & Data Officer
|
GrantRestricted Stock Units · Derivative | 4,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000085 · wk-form4_1741819997.xml · derivative · entry 1 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,828 Underlying: Common Stock · 4,828 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 18:53 UTC |
Tillett CarolineChief Scientific Officer
|
GrantStock Options · Derivative | 81,837 | $0.00 Strike: $23.92 | $0.00 |
DisclosureSEC source: 0001944048-25-000088 · wk-form4_1741820029.xml · derivative · entry 2 Tillett Caroline · CIK 0001966949 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,837 Underlying: Common Stock · 81,837 shares Expires 2035-03-10 F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 18:53 UTC |
Tillett CarolineChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 9,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000088 · wk-form4_1741820029.xml · derivative · entry 1 Tillett Caroline · CIK 0001966949 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,807 Underlying: Common Stock · 9,807 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 18:53 UTC |
Stevens MeredithChief Operations Officer
|
GrantStock Options · Derivative | 128,197 | $0.00 Strike: $23.92 | $0.00 |
DisclosureSEC source: 0001944048-25-000083 · wk-form4_1741819977.xml · derivative · entry 2 Stevens Meredith · CIK 0001967093 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,197 Underlying: Common Stock · 128,197 shares Expires 2035-03-10 F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 18:53 UTC |
Stevens MeredithChief Operations Officer
|
GrantRestricted Stock Units · Derivative | 15,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000083 · wk-form4_1741819977.xml · derivative · entry 1 Stevens Meredith · CIK 0001967093 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,363 Underlying: Common Stock · 15,363 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:54 UTC |
Ruh PaulChief Financial Officer
|
GrantStock Options · Derivative | 128,093 | $0.00 Strike: $23.92 | $0.00 |
DisclosureSEC source: 0001944048-25-000094 · wk-form4_1741820089.xml · derivative · entry 2 Ruh Paul · CIK 0001967445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,093 Underlying: Common Stock · 128,093 shares Expires 2035-03-10 F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:54 UTC |
Ruh PaulChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 15,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000094 · wk-form4_1741820089.xml · derivative · entry 1 Ruh Paul · CIK 0001967445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,351 Underlying: Common Stock · 15,351 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:54 UTC |
Meurer JanGroup President, North America
|
GrantStock Options · Derivative | 113,023 | $0.00 Strike: $23.92 | $0.00 |
DisclosureSEC source: 0001944048-25-000092 · wk-form4_1741820067.xml · derivative · entry 2 Meurer Jan · CIK 0001967057 · Group President, North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,023 Underlying: Common Stock · 113,023 shares Expires 2035-03-10 F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:54 UTC |
Meurer JanGroup President, North America
|
GrantRestricted Stock Units · Derivative | 13,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000092 · wk-form4_1741820067.xml · derivative · entry 1 Meurer Jan · CIK 0001967057 · Group President, North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,545 Underlying: Common Stock · 13,545 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:54 UTC |
Orlando MatthewGeneral Counsel
|
GrantStock Options · Derivative | 136,220 | $0.00 Strike: $23.92 | $0.00 |
DisclosureSEC source: 0001944048-25-000093 · wk-form4_1741820079.xml · derivative · entry 2 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,220 Underlying: Common Stock · 136,220 shares Expires 2035-03-10 F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:54 UTC |
Orlando MatthewGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 16,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000093 · wk-form4_1741820079.xml · derivative · entry 1 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,325 Underlying: Common Stock · 16,325 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:54 UTC |
Xie BingGroup President APAC
|
GrantStock Options · Derivative | 88,731 | $0.00 Strike: $23.92 | $0.00 |
DisclosureSEC source: 0001944048-25-000091 · wk-form4_1741820058.xml · derivative · entry 2 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,731 Underlying: Common Stock · 88,731 shares Expires 2035-03-10 F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:54 UTC |
Xie BingGroup President APAC
|
GrantRestricted Stock Units · Derivative | 10,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000091 · wk-form4_1741820058.xml · derivative · entry 1 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,633 Underlying: Common Stock · 10,633 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:54 UTC |
Alvarado LuaniChief People Officer
|
GrantStock Options · Derivative | 104,389 | $0.00 Strike: $23.92 | $0.00 |
DisclosureSEC source: 0001944048-25-000090 · wk-form4_1741820049.xml · derivative · entry 2 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,389 Underlying: Common Stock · 104,389 shares Expires 2035-03-10 F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:54 UTC |
Alvarado LuaniChief People Officer
|
GrantRestricted Stock Units · Derivative | 12,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000090 · wk-form4_1741820049.xml · derivative · entry 1 Alvarado Luani · CIK 0001967089 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,510 Underlying: Common Stock · 12,510 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:53 UTC |
Lawson CarltonGroup President EMEA & LA
|
GrantStock Options · Derivative | 147,851 | $0.00 Strike: $23.92 | $0.00 |
DisclosureSEC source: 0001944048-25-000087 · wk-form4_1741820020.xml · derivative · entry 2 Lawson Carlton · CIK 0001967003 · Group President EMEA & LA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,851 Underlying: Common Stock · 147,851 shares Expires 2035-03-10 F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:53 UTC |
Lawson CarltonGroup President EMEA & LA
|
GrantRestricted Stock Units · Derivative | 17,719 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000087 · wk-form4_1741820020.xml · derivative · entry 1 Lawson Carlton · CIK 0001967003 · Group President EMEA & LA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,719 Underlying: Common Stock · 17,719 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:53 UTC |
Mongon ThibautDirector · Chief Executive Officer
|
GrantStock Options · Derivative | 569,040 | $0.00 Strike: $23.92 | $0.00 |
DisclosureSEC source: 0001944048-25-000084 · wk-form4_1741819986.xml · derivative · entry 2 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 569,040 Underlying: Common Stock · 569,040 shares Expires 2035-03-10 F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:53 UTC |
Mongon ThibautDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 68,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000084 · wk-form4_1741819986.xml · derivative · entry 1 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,196 Underlying: Common Stock · 68,196 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 17:02 UTC |
England CharmaineChief Growth Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,910.73 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000061 · wk-form4_1741384916.xml · derivative · entry 3 England Charmaine · CIK 0002003894 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,819.46 Underlying: Common Stock · 2,910.73 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F3 · derivative.exercise_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date. F3 · derivative.expiration_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date. F4 · balance_after: Includes RSUs acquired as dividend equivalents. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 17:02 UTC |
England CharmaineChief Growth Officer
|
Tax withholdingCommon Stock | 1,348 | $23.04 | $31,057.92 |
DisclosureSEC source: 0001944048-25-000061 · wk-form4_1741384916.xml · nonDerivative · entry 2 England Charmaine · CIK 0002003894 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,058.73 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units (RSUs). Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 17:02 UTC |
England CharmaineChief Growth Officer
|
Exercise / conversionCommon Stock | 2,910.73 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000061 · wk-form4_1741384916.xml · nonDerivative · entry 1 England Charmaine · CIK 0002003894 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,406.73 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These units correspond 1 for 1 with the Company's common stock. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 17:02 UTC |
Tavares BernardoChief Tech & Data Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,502.65 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000065 · wk-form4_1741384955.xml · derivative · entry 3 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,119.27 Underlying: Common Stock · 1,502.65 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F3 · derivative.exercise_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date. F3 · derivative.expiration_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date. F4 · balance_after: Includes RSUs acquired as dividend equivalents. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 17:02 UTC |
Tavares BernardoChief Tech & Data Officer
|
Tax withholdingCommon Stock | 580 | $23.04 | $13,363.20 |
DisclosureSEC source: 0001944048-25-000065 · wk-form4_1741384955.xml · nonDerivative · entry 2 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,001.65 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units RSUs. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 17:02 UTC |
Tavares BernardoChief Tech & Data Officer
|
Exercise / conversionCommon Stock | 1,502.65 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000065 · wk-form4_1741384955.xml · nonDerivative · entry 1 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,581.65 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These units correspond 1 for 1 with the Company's common stock. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 17:03 UTC |
Tillett CarolineChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,267.56 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000068 · wk-form4_1741384985.xml · derivative · entry 3 Tillett Caroline · CIK 0001966949 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,533.13 Underlying: Common Stock · 4,267.56 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F3 · derivative.exercise_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date. F3 · derivative.expiration_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date. F4 · balance_after: Includes RSUs acquired as dividend equivalents. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 17:03 UTC |
Tillett CarolineChief Scientific Officer
|
Tax withholdingCommon Stock | 1,529 | $23.04 | $35,228.16 |
DisclosureSEC source: 0001944048-25-000068 · wk-form4_1741384985.xml · nonDerivative · entry 2 Tillett Caroline · CIK 0001966949 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,128.76 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units (RSUs). Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 17:03 UTC |
Tillett CarolineChief Scientific Officer
|
Exercise / conversionCommon Stock | 4,267.56 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000068 · wk-form4_1741384985.xml · nonDerivative · entry 1 Tillett Caroline · CIK 0001966949 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,657.76 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These units correspond 1 for 1 with the Company's common stock. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 17:01 UTC |
Stevens MeredithChief Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,971.27 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000058 · wk-form4_1741384887.xml · derivative · entry 3 Stevens Meredith · CIK 0001967093 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,337.02 Underlying: Common Stock · 5,971.27 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F3 · derivative.exercise_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date. F3 · derivative.expiration_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date. F4 · balance_after: Includes RSUs acquired as dividend equivalents. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.